163 related articles for article (PubMed ID: 11122019)
1. Analysis of dendritic cell populations using a revised histological staging of morphoea.
Gilmour TK; Wilkinson B; Breit SN; Kossard S
Br J Dermatol; 2000 Dec; 143(6):1183-92. PubMed ID: 11122019
[TBL] [Abstract][Full Text] [Related]
2. CD34 stromal expression is inversely proportional to smooth muscle actin expression and extent of morphea.
Lee JS; Park HS; Yoon HS; Chung JH; Cho S
J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2208-2216. PubMed ID: 29888507
[TBL] [Abstract][Full Text] [Related]
3. Factor XIIIa-positive dermal dendritic cells and HLA-DR expression in radial versus vertical growth-phase melanomas.
Fullen DR; Headington JT
J Cutan Pathol; 1998 Nov; 25(10):553-8. PubMed ID: 9870675
[TBL] [Abstract][Full Text] [Related]
4. Immunocytochemical localization and serologic detection of transforming growth factor beta 1. Association with type I procollagen and inflammatory cell markers in diffuse and limited systemic sclerosis, morphea, and Raynaud's phenomenon.
Higley H; Persichitte K; Chu S; Waegell W; Vancheeswaran R; Black C
Arthritis Rheum; 1994 Feb; 37(2):278-88. PubMed ID: 7510487
[TBL] [Abstract][Full Text] [Related]
5. Elastic fiber pattern in scleroderma/morphea.
Walters R; Pulitzer M; Kamino H
J Cutan Pathol; 2009 Sep; 36(9):952-7. PubMed ID: 19674200
[TBL] [Abstract][Full Text] [Related]
6. Morphea limited to the superficial reticular dermis: an underrecognized histologic phenomenon.
McNiff JM; Glusac EJ; Lazova RZ; Carroll CB
Am J Dermatopathol; 1999 Aug; 21(4):315-9. PubMed ID: 10446770
[TBL] [Abstract][Full Text] [Related]
7. Morphoea with prominent plasma cell endoneuritis.
Singh M; Farquharson N; Owen C; Howat AJ; Singh S; Francis N; Calonje E
Clin Exp Dermatol; 2017 Mar; 42(2):196-199. PubMed ID: 28052367
[TBL] [Abstract][Full Text] [Related]
8. Localized and systemic scleroderma show different histological responses to methotrexate therapy.
Seyger MM; van den Hoogen FH; van Vlijmen-Willems IM; van de Kerkhof PC; de Jong EM
J Pathol; 2001 Apr; 193(4):511-6. PubMed ID: 11276011
[TBL] [Abstract][Full Text] [Related]
9. Clinical, histological and high-frequency ultrasonographic evaluation (50 MHz) of morphoea treated with ultraviolet A1 phototherapy.
Arisi M; Lorenzi L; Incardona P; Fusano M; Zanca A; Rossi MT; Tomasi C; Calzavara-Pinton PG; Venturini M
Clin Exp Dermatol; 2019 Apr; 44(3):270-276. PubMed ID: 29974485
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical analysis of transforming growth factor beta 3 expression in solitary morphoea profunda with histological membranocystic changes.
Kawakami T; Soma Y; Baba T; Mizoguchi M; Matsuzaki K; Kumagai N
Br J Dermatol; 2002 Jan; 146(1):171-3. PubMed ID: 11852924
[No Abstract] [Full Text] [Related]
11. Subcutaneous morphoea: a clinical study of sixteen cases.
Person JR; Su WP
Br J Dermatol; 1979 Apr; 100(4):371-80. PubMed ID: 454564
[TBL] [Abstract][Full Text] [Related]
12. Pulsed dye laser in the treatment of localized scleroderma and its effects on CD34+ and factor XIIIa+ cells: an immunohistochemical study.
Tawfik AA; Shokir H; Soliman M; Salah L; Fathy S
Am J Clin Dermatol; 2013 Jun; 14(3):235-41. PubMed ID: 23645504
[TBL] [Abstract][Full Text] [Related]
13. Adult variant of self-healing papular mucinosis in a patient with rheumatoid arthritis: predominant proliferation of dermal dendritic cells expressing CD34 or factor XIIIa in association with dermal deposition of mucin.
Yokoyama E; Muto M
J Dermatol; 2006 Jan; 33(1):30-5. PubMed ID: 16469081
[TBL] [Abstract][Full Text] [Related]
14. First case series on the use of imiquimod for morphoea.
Dytoc M; Ting PT; Man J; Sawyer D; Fiorillo L
Br J Dermatol; 2005 Oct; 153(4):815-20. PubMed ID: 16181467
[TBL] [Abstract][Full Text] [Related]
15. CD34+ spindle-shaped cells selectively disappear from the skin lesion of scleroderma.
Aiba S; Tabata N; Ohtani H; Tagami H
Arch Dermatol; 1994 May; 130(5):593-7. PubMed ID: 7513987
[TBL] [Abstract][Full Text] [Related]
16. Decreased expression of the human progenitor cell antigen (CD34) in morphea.
Skobieranda K; Helm KF
Am J Dermatopathol; 1995 Oct; 17(5):471-5. PubMed ID: 8599452
[TBL] [Abstract][Full Text] [Related]
17. Regulatory T cells in the skin lesions and blood of patients with systemic sclerosis and morphoea.
Antiga E; Quaglino P; Bellandi S; Volpi W; Del Bianco E; Comessatti A; Osella-Abate S; De Simone C; Marzano A; Bernengo MG; Fabbri P; Caproni M
Br J Dermatol; 2010 May; 162(5):1056-63. PubMed ID: 20105169
[TBL] [Abstract][Full Text] [Related]
18. [Systemic sclerosis and scleroderma circumscripta--disturbances of selected serum parameters which are responsible for vascular changes and CD34 expression in involved skin].
Dziankowska-Bartkowiak B; Zebrowska A; Wagrowska-Danielewicz M; Kobos J; Waszczykowska E
Przegl Lek; 2009; 66(12):1040-5. PubMed ID: 20514902
[TBL] [Abstract][Full Text] [Related]
19. Dermal dendritic cell population and blood vessels are diminished in the skin of systemic sclerosis patients: relationship with fibrosis degree and disease duration.
de-Sá-Earp AP; do Nascimento AP; Carneiro SC; Porto LC; Monte-Alto-Costa A
Am J Dermatopathol; 2013 Jun; 35(4):438-44. PubMed ID: 23262669
[TBL] [Abstract][Full Text] [Related]
20. Expression of transforming growth factor-beta and platelet-derived growth factor in linear scleroderma.
Restrepo JF; Guzmán R; Rodríguez G; Iglesias A
Biomedica; 2003 Dec; 23(4):408-15. PubMed ID: 14968919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
